Provided by Tiger Trade Technology Pte. Ltd.

iRadimed

99.81
-0.0300-0.03%
Post-market: 99.810.00000.00%17:21 EST
Volume:58.25K
Turnover:5.86M
Market Cap:1.27B
PE:57.03
High:102.34
Open:99.36
Low:99.36
Close:99.84
52wk High:107.90
52wk Low:47.48
Shares:12.72M
Float Shares:7.17M
Volume Ratio:0.76
T/O Rate:0.81%
Dividend:0.68
Dividend Rate:0.68%
EPS(TTM):1.75
EPS(LYR):1.75
ROE:24.78%
ROA:15.78%
PB:13.42
PE(LYR):57.03

Loading ...

IRADIMED Dividend Hike Follows Record Revenue And New MRI Pump Rollout

Simply Wall St.
·
Feb 14

IRadimed Director Monty K. Allen Reports Sale of Common Shares

Reuters
·
Feb 14

iRadimed price target raised to $120 from $98 at Roth Capital

TIPRANKS
·
Feb 11

Stock Track | iRadimed Soars 8.95% Intraday on Strong Q4 Earnings Beat and Raised Dividend

Stock Track
·
Feb 10

IRadimed Raises Quarterly Dividend by 18%

Dow Jones
·
Feb 10

GUIDANCE: (IRMD) Iradimed Expects 2026 Adjusted EPS Range $2.06 to $2.21, vs. FactSet Est of $2.12

MT Newswires Live
·
Feb 10

GUIDANCE: (IRMD) IRadimed Expects 2026 Revenue Range $91M to $96M, vs. FactSet Est of $91.1M

MT Newswires Live
·
Feb 10

IRMD Q4 net income rises 25% to USD 6.4 million

Reuters
·
Feb 10

iRadimed Q4 Adj. EPS $0.54 Beats $0.48 Estimate, Sales $22.692M Beat $21.600M Estimate

Benzinga
·
Feb 10

BRIEF-IRadimed Q4 Revenue USD 22.7 Million

Reuters
·
Feb 10

IRadimed Projects 2026 Revenue Up to $96 Million and EPS Up to $2.21

Reuters
·
Feb 10

IRadimed Corporation Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases Its Regular Quarterly Cash Dividend to $0.20 per Share From $0.17 per Share

THOMSON REUTERS
·
Feb 10

IRadimed Q4 Adjusted EPS USD 0.54

THOMSON REUTERS
·
Feb 10

IRadimed Outlook Q1 Revenue USD 21-22 Million

THOMSON REUTERS
·
Feb 10

IRadimed Outlook Q1 EPS USD 0.39-0.43

THOMSON REUTERS
·
Feb 10

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

GlobeNewswire
·
Feb 10

The total return for IRADIMED (NASDAQ:IRMD) investors has risen faster than earnings growth over the last five years

Simply Wall St.
·
Feb 06

IRadimed Corporation to Release Fourth Quarter and Full Year Financial Results

Reuters
·
Feb 05

IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026

GlobeNewswire
·
Feb 05

IRadimed CEO Roger E. Susi Reports Disposal of Common Shares

Reuters
·
Jan 28